Explore the latest in melanoma, including advances in screening, prevention, diagnosis, and management of local and metastatic disease.
This cohort study identifies the dermoscopic features of subungual melanoma in situ in a Korean population and assesses a predictive scoring model that distinguishes the diagnosis of subungual melanoma in situ from longitudinal melanonychia in patients with pigmented nails.
This case-control study evaluates the association of melanocortin-1-receptor (MC1R) with melanoma risk in males vs females, adjusting for risk factors such as age, pigmentation, phenotype, signs of skin damage, and sun exposure.
This diagnostic study compares the training efficacy of a novel web-based application to the publicly available Internet Curriculum For Melanoma Early Detection Skin Education Series to determine if intuitive visual diagnosis training is superior to a traditional rule-based algorithm in the diagnosis of melanomas.
This randomized clinical trial examines the prevalence of interest in and uptake of MC1R testing in the general population and examines patterns across demographic and skin cancer risk factors.
This Insights discusses management strategies for metastatic melanoma using the most recent therapeutic options.
This medical record review examines the rate of recurrence of lentigo maligna in patients treated with neoadjuvant topical imiquimod, 5%, cream prior to conservatively staged excisions.
This case-control study assesses the association of hydrochlorothiazide with risk of malignant melanoma among Danish adults.
This case report describes 2 patients with cutaneous eruptions secondary to immunotherapy for metastatic melanoma limited to sites of locoregional melanoma metastases.
This diagnostic accuracy study evaluates whether changes to the definitions of T1a and T1b or greater invasive melanoma staging between the AJCC Cancer Staging Manual 7th and 8th editions by the American Joint Committee on Cancer (AJCC) led to changes in the concordance and reproducibility of pathologists’ readings of melanocytic skin biopsies compared with a consensus reference standard.
This cohort study assesses the speed with which inhibitors of programmed cell death 1 protein reached eligible patients in practice and compares the ages of patients treated in clinical practice with the ages of those treated in pivotal clinical trials.
This case series describes a relatively large cohort of patients with uveal melanoma associated with myotonic dystrophy, including a case of iris melanoma, and myotonic dystrophy–associated uveal melanoma in relatives.
This case series examines the yield rates for transscleral and transvitreal fine-needle aspiration biopsies of small uveal melanoma.
This cohort study examines the incidence and timing of presentation of malignant melanoma in the cardiothoracic (heart and/or lung) transplant population.
This case report describes a patient with advanced melanoma initially resistant to nivolumab therapy, treated with vemurafenib, and then rechallenged with nivolumab after development of vemurafenib-related adverse effects.
This population-based study evaluates the association between marital status and T stage at the time of presentation and the decision for sentinel lymph node biopsy in patients with early-stage melanoma included in the Surveillance, Epidemiology, and End Results database.
This cross-sectional pooled analysis analyzes the association between skin examination practices and diagnosis with thin nodular or superficial spreading melanoma.
This cohort study assesses whether baseline and early therapy circulating tumor DNA measurements differentiate pseudoprogression from true progression in patients with metastatic melanoma treated with anti–programmed cell death 1 antibodies.
Customize your JAMA Network experience by selecting one or more topics from the list below.